| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC4286 | Psb-1491 Featured | Highly potent, selective, competitive, and reversible inhibitor of monoamine oxidase B (MAO-B) |
|
| DCC4287 | Psb-16131 | Novel potent Lp1NTPDase inhibitor |
|
| DCC4288 | Psb-16133 | Novel Potent and Selective Antagonist for the UTP-Activated P2Y4 Receptor |
|
| DCC4289 | Psb-16282 | Novel Potent Agonist of the Orphan G Protein-Coupled Receptor GPR17 (EC 50 12 nM) |
|
| DCC4290 | Psb-16434 | Novel potent and selective agonist of the orphan G protein-coupled receptor 84 (GPR84) |
|
| DCC4291 | Psb-18332 | Fluorescent Probe for Ecto-5'--nucleotidase (CD73) |
|
| DCC4292 | Psb-18422 | Novel Potent Agonist of the Orphan G Protein-Coupled Receptor GPR17 (EC 50 27.9 nM) |
|
| DCC4293 | Psb-18484 | Novel Potent Agonist of the Orphan G Protein-Coupled Receptor GPR17 (EC 50 32.1 nM) |
|
| DCC4294 | Psb-19416 | Fluorescent Probe for Ecto-5'--nucleotidase (CD73) |
|
| DCC4295 | Psb-6426 | The first potent and selective inhibitor of human nucleoside triphosphate diphosphohydrolase-2 (NTPDase2) |
|
| DCC4296 | Psb-kd107 | Novel Agonist of the Cannabinoid-Activated Orphan G-Protein-Coupled Receptor GPR18, being selective versus the CB-sensitive receptors CB1, CB2, and GPR55 |
|
| DCC4297 | Psb-kd477 | Novel Agonist of the Cannabinoid-Activated Orphan G-Protein-Coupled Receptor GPR18, being selective versus the CB-sensitive receptors CB1, CB2, and GPR55 |
|
| DCC4298 | psb-sb-1203 | Potent GPR55 antagonist |
|
| DCC4299 | psb-sb-489 | Novel Selective, competitive GPR55 antagonist |
|
| DCC4300 | Psma-1092 | Novel Highly Sensitive PSMA Probe for NIR-II Imaging and Intraoperative Tumor Resection, Visualizing Tumors in Real Time |
|
| DCC4301 | Psma-sulfocy7 | Novel PSMA ligand conjugated with fluorescent dye SulfoCy7, demonstrating good visualization of PSMA-expressing tumors and the absence of any explicit toxicity up to 87.9 mg/kg |
|
| DCC4302 | Pst2774 Oxalate | Na-K ATPase inhibitor, stimulating SERCA2a and accelerating calcium cycling in heart failure by relieving phospholamban inhibition |
|
| DCC4303 | Ptc-12 | Novel Bovine Viral Diarrhea (BVD) Inhibitor, specifically blocking BVDV cell entry |
|
| DCC4304 | Ptc-510 Tfa Salt | Novel inhibitor of hypoxia-induced VEGF expression |
|
| DCC4305 | Pterophyllin 2 | Natural antifungal agent, against postharvest fruit pathogenic fungi |
|
| DCC4306 | Pti-ch | Novel CFTR modulator, increasing CFTR protein expression across different mutations, including F508del, by increasing CFTR mRNA levels by ~1.5 to ~2-fold in HBE cells |
|
| DCC4307 | Pti-cv | Novel CFTR modulator, binding to the poly-r(C) binding protein 1 (PCBP1), showing an affinity for RNA-bound PCBP1 higher than that of free PCBP1 |
|
| DCC4308 | Ptk6-in-21b | Novel Brk/PTK6 kinase inhibitor |
|
| DCC4309 | Ptk7/ß-catenin Inhibitor 01065 | Novel Inhibitor of the PTK7/β-Catenin Interaction Targeting the Wnt Signaling Pathway in Colorectal Cancer |
|
| DCC4310 | Ptk7/ß-catenin Inhibitor 03653 | Novel Inhibitor of the PTK7/β-Catenin Interaction Targeting the Wnt Signaling Pathway in Colorectal Cancer |
|
| DCC4311 | Ptk-in-6a | Novel Potent Multi-target PTK Inhibitor for the Treatment of Idiopathic Pulmonary Fibrosis (IPF) |
|
| DCC4312 | Ptk-sma1 | Unique promoter of SMN2 exon 7 splicing, acting by directly stimulating splicing of exon 7 |
|
| DCC4313 | Pto-41 | Novel NIR fluorescent probe for the detection of Aβ oligomers |
|
| DCC4314 | Ptp1b-in-18k | Novel non-competitive potent and selective inhibitor of protein tyrosine phosphatase 1B (PTP1B) |
|
| DCC4315 | Ptpmt1-in-1 | Novel PTEN-like mitochondrial phosphatase PTPMT1 inhibitor |
|
